The document discusses the accomplishments and future plans of the American Journal of Physiology - Lung Cellular and Molecular Physiology (AJP-Lung) from 2012-2015. Some key accomplishments include increasing the journal's impact factor, reducing the time to first decision on manuscripts, and establishing new article types. Challenges addressed were declining submission rates and visibility. Future plans aim to further increase submissions and visibility through new calls for papers, sponsoring symposia, and highlighting influential papers. The editor expresses optimism about the journal's upward momentum.
- Kenneth W. Rundell has over 25 years of experience in regulatory affairs, medical writing, and research. He has expertise in areas such as medical writing, regulatory submissions, adverse event reporting, and electronic document management systems.
- He has a strong background managing multiple projects simultaneously and applying regulatory standards. He also has skills in areas like data management, controlled documentation, and presentation.
- Rundell has held roles as a Director of Medical Affairs and regulatory consultant. He was also a professor conducting research studies in areas like asthma, air pollution, and cardiovascular health.
The document summarizes the achievements and challenges of the American Journal of Physiology - Lung Cellular and Molecular Physiology in 2013. It discusses the journal's mission, editorial board changes, publishing accomplishments such as Physiology in Medicine articles and review articles, and awards given to outstanding new investigators. It also outlines challenges for 2014 such as increasing impact factor and manuscript submissions.
International Journal of Anatomy & Applied Physiology (IJAAP) is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of academic and clinical anatomy, as well as the entire scope of physiology, from the cellular and molecular levels to the organ and system levels.
IJAAP publishes high quality papers, rapid communications, original papers, research letters, and case reports pertaining to studies in the fields of anatomy & applied physiology.
IJAAP brings scientific findings, new techniques, and opinions on anatomy and physiological research to a wide audience of scholars, educators, and information specialists around the globe.
Modeling the cost effectiveness of two big league pay-for-performance policiescheweb1
This document summarizes Ankur Pandya's presentation on using cost-effectiveness analysis (CEA) to evaluate two pay-for-performance (P4P) policies. It discusses modeling done to evaluate the cost-effectiveness of financial incentives in a randomized controlled trial that linked incentives to cholesterol control. The modeling found that a shared incentives strategy was cost-effective under certain assumptions about how long the effects of the intervention persisted. It also discusses CEA modeling done to evaluate the UK's Quality and Outcomes Framework primary care P4P program, finding it was not cost-effective unless costs were lower or effects were higher.
This document summarizes the key points from the 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care regarding adult advanced cardiovascular life support. It discusses adjuncts to CPR such as oxygen dose, monitoring physiologic parameters, and use of ultrasound. It also covers adjuncts for airway control and ventilation such as bag-mask ventilation versus advanced airways. The major changes in the 2015 ACLS guidelines are recommendations about prognostication during CPR using exhaled carbon dioxide measurements, timing of epinephrine administration based on rhythm, and possible bundling of steroids, vasopressin, and epinephrine for in-hospital arrests.
There have been a variety of announcements recently about wearable devices “new” capabilities around atrial fibrilation and arrythmia detection, hydration tracking, and more. These capabilities are being delivered by the same optical heart rate sensors using PPG that are found in many wearable devices today. These are not necessarily new capabilities and some have been proven capabilities for many years. In many ways we are just scratching the surface of what’s possible. This webinar will share details on all the things that have been scientifically validated possible with PPG, many of which you may not be aware of.
- Kenneth W. Rundell has over 25 years of experience in regulatory affairs, medical writing, and research. He has expertise in areas such as medical writing, regulatory submissions, adverse event reporting, and electronic document management systems.
- He has a strong background managing multiple projects simultaneously and applying regulatory standards. He also has skills in areas like data management, controlled documentation, and presentation.
- Rundell has held roles as a Director of Medical Affairs and regulatory consultant. He was also a professor conducting research studies in areas like asthma, air pollution, and cardiovascular health.
The document summarizes the achievements and challenges of the American Journal of Physiology - Lung Cellular and Molecular Physiology in 2013. It discusses the journal's mission, editorial board changes, publishing accomplishments such as Physiology in Medicine articles and review articles, and awards given to outstanding new investigators. It also outlines challenges for 2014 such as increasing impact factor and manuscript submissions.
International Journal of Anatomy & Applied Physiology (IJAAP) is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of academic and clinical anatomy, as well as the entire scope of physiology, from the cellular and molecular levels to the organ and system levels.
IJAAP publishes high quality papers, rapid communications, original papers, research letters, and case reports pertaining to studies in the fields of anatomy & applied physiology.
IJAAP brings scientific findings, new techniques, and opinions on anatomy and physiological research to a wide audience of scholars, educators, and information specialists around the globe.
Modeling the cost effectiveness of two big league pay-for-performance policiescheweb1
This document summarizes Ankur Pandya's presentation on using cost-effectiveness analysis (CEA) to evaluate two pay-for-performance (P4P) policies. It discusses modeling done to evaluate the cost-effectiveness of financial incentives in a randomized controlled trial that linked incentives to cholesterol control. The modeling found that a shared incentives strategy was cost-effective under certain assumptions about how long the effects of the intervention persisted. It also discusses CEA modeling done to evaluate the UK's Quality and Outcomes Framework primary care P4P program, finding it was not cost-effective unless costs were lower or effects were higher.
This document summarizes the key points from the 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care regarding adult advanced cardiovascular life support. It discusses adjuncts to CPR such as oxygen dose, monitoring physiologic parameters, and use of ultrasound. It also covers adjuncts for airway control and ventilation such as bag-mask ventilation versus advanced airways. The major changes in the 2015 ACLS guidelines are recommendations about prognostication during CPR using exhaled carbon dioxide measurements, timing of epinephrine administration based on rhythm, and possible bundling of steroids, vasopressin, and epinephrine for in-hospital arrests.
There have been a variety of announcements recently about wearable devices “new” capabilities around atrial fibrilation and arrythmia detection, hydration tracking, and more. These capabilities are being delivered by the same optical heart rate sensors using PPG that are found in many wearable devices today. These are not necessarily new capabilities and some have been proven capabilities for many years. In many ways we are just scratching the surface of what’s possible. This webinar will share details on all the things that have been scientifically validated possible with PPG, many of which you may not be aware of.
This document provides guidance on publishing research in the journal AJP-Lung. It discusses the importance of publication for career advancement and continued funding. It outlines best practices for authorship, including determining author order and meeting authorship criteria. The submission and review process is described, including timelines, criteria for acceptance/rejection, and responding to reviewer feedback. Ethical issues in publishing like plagiarism, data fabrication, and authorship disputes are also covered. The document aims to help researchers successfully publish their work in AJP-Lung.
Ajp lung accomplishments 2015-updated by sm 3_31_2016amcever
The American Journal of Physiology-Lung Cellular and Molecular Physiology annual report summarizes accomplishments and challenges in 2015-2016. Key accomplishments include a 20% increase in research manuscript submissions, an increased impact factor of 4.08 making it the highest ranked basic lung research journal, and a 60% acceptance rate for research manuscripts. The journal also published three of the most highly cited articles among all APS journals and selected thirteen manuscripts for the APSselect program which highlights innovative, high impact research.
Can Cardiovascular Disease be PreventedParticipantsA.docxhumphrieskalyn
Can Cardiovascular Disease be Prevented?
Participants
:
Alfred A. Bove, MD, PhD, F
Robert S. Schwartz, MD, FACC
COPYRIGHT 2012 Healthology Inc.
Cardiovascular disease affects all aspects of heart function, from the arteries that supply it with blood, to the valves to the heart muscle itself.
RICHARD P. LEWIS, MD: Cardiovascular disease is the commonest chronic illness in our society, and I think in the world now. It causes about half of the deaths in our country today in one form or another, either as a heart attack or sudden death or dying of congestive heart failure.
Strokes are also a manifestation of cardiovascular disease, and a final one is called intermittent claudication, which is disease to the leg blood vessels that may lead to an amputation of the legs if it's severe.
ANNOUNCER: There are factors that can add to a patient's risk for the disease.
SUZANNE HUGHES, MSN, RN: There are only three risk factors for heart disease that we can't change. We haven't found the Fountain of Youth, so we can't turn back the clock: Age is a huge risk factor for cardiovascular disease. Being a man early in life is a risk factor for heart disease, which certainly is not changeable. And then the third thing is that we can't choose our parents. Family history is a risk factor for cardiovascular disease.
ANNOUNCER: Different medications can be prescribed to help prevent or control cardiovascular disease
ADOLPH M. HUTTER, Jr., MD: There are a number of medications that are actually very effective in preventing heart attacks and other forms of atherosclerosis. One is the simple drug aspirin. Aspirin has been shown to reduce strokes in women and heart attacks in men.
Another very important class of drugs are the drugs called statins. The statins are drugs that lower the bad cholesterol, the LDL. They lower it very effectively, and many studies have shown that these drugs can prevent the onset of heart disease and the progression of heart disease if you already have it.
A class of drugs called beta blockers can be very effective in protecting people who have already had a heart attack. They're also helpful in controlling blood pressure and controlling angina, which is a symptom of chest discomfort due to a blockage in the artery.
ANNOUNCER: It is also crucial that a patient makes lifestyle modifications.
ADOLPH M. HUTTER, Jr., MD: Heart disease is very preventable. You must absolutely stop smoking. You must have a low cholesterol, particularly the low bad cholesterol, the LDL. You must have your blood pressure controlled. You should exercise regularly and keep a lean weight.
RICHARD P. LEWIS, MD: We have made enormous strides in treating cardiovascular disease in all types. We can prevent the progression of this disease or the occurrence of clinically significant disease with our modern treatments if people will but do them. And it's not a disaster, even if you have the disease
Source Citation :
Can Cardiovascular Disease be Prevented? Alfre ...
The meeting agenda provided an update on research activities and future plans for the REG Interstitial Lung Disease Working Group. David Price discussed ongoing and upcoming research studies, publications, and events. Future plans included a revised staffing structure, working group and council structure, and upcoming events in 2015 and 2016. The meeting also discussed driving quality standards, perspectives from industry supporters, and new funding opportunities like PCORI. An open discussion period concluded the meeting to gather feedback and ideas.
How to Read a Research Article? By Dr. Nizar Saleh Abdelfattah, 2017Kareem Alnakeeb
This presentation is created by Dr. Nizar Saleh Abdelfattah in 2017. He used it in his episodes of "Research Fundamentals For Dummies" on YouTube.
https://www.youtube.com/playlist?list=PLuDFktFSWZ_XVufo7h9bDIerKoo7s3ouA
* The original presentation on Mediafire:
http://www.mediafire.com/file/mu5dml695g5r8qf/How-to-Research-by-Nizar-Abdelfattah.pptx/file
This document lists the collaborations and conflicts of interest for speakers Thomas F. Lüscher and Marco Metra. It notes that they have received research grants, educational grants, and honoraria from numerous pharmaceutical companies. The rest of the document discusses the European Heart Journal, including new associate editors, submission rates and acceptance rates, impact factors, and plans to launch new open access and supplement journals.
Getting the Measure of Analytics: Using bibliometrics and usage statistics to...Fintan Bracken
Presentation by Fintan Bracken and Arlene Healy entitled 'Getting the Measure of Analytics: Using bibliometrics and usage statistics to evaluate e-journals' delivered at the Academic & Special Libraries Section Annual Conference 2015 'The inside out library: collaboration, inspiration, transformation' in The Gibson Hotel, Dublin on 26th February 2015
Fintan Bracken & Arlene Healy presentation 'Getting the measure of analytics' delivered at #asl2015 'The inside out library: collaboration, inspiration, transformation' Feb 27th 2015
This document discusses electronic publishing (e-publishing) and impact factors (IF). It explains that e-publishing includes open access, and that impact factors are a measure of the frequency with which articles in a journal are cited. The document also lists several references on topics like how to write papers, guidelines for scientific publication, plagiarism, and publication ethics.
- Patrick W. Serruys is the editor-in-chief of EuroIntervention, which has reached its 10th anniversary as the official journal of the European Association of Percutaneous Cardiovascular Interventions.
- Over the past 10 years, the journal has grown tremendously due to the need to publish impactful presentations from EuroPCR and innovations from young cardiologists, as well as its inclusion in PubMed and increasing impact factor.
- The editorial board has played a key role in the journal's success through their expertise, enthusiasm, and awareness of current developments in the field.
Primer in quality improvement in radiology departmentAhmed Bahnassy
This document provides guidance on developing and implementing a quality improvement plan for a radiology department. It discusses identifying areas for improvement, collecting relevant data, setting targets, developing a work plan, implementing changes, monitoring results, and continually refining the process. Key aspects of quality improvement covered include using tools like fishbone diagrams and SWOT analyses to identify root causes of issues, applying the PDSA (Plan-Do-Study-Act) cycle of testing changes, and developing standardized reporting templates to improve consistency and communication. Examples of specific quality improvement projects focused on areas like lumbar spine MRI reporting and management of indeterminate pulmonary nodules are also provided.
The document discusses the first five years of publication of the Annals of Pakistan Institute of Medical Sciences (Annals of PIMS) journal from 2005 to 2009. Over these five years, the journal published 335 papers across various categories and specialties. The journal has provided a platform for disseminating medical research and works to improve through developing clear editorial policies and increasing its indexing in databases. Going forward, the journal aims to further improve quality, increase citations, and pursue indexing in international databases.
This document summarizes the structure and process for developing ESMO (European Society for Medical Oncology) clinical practice guidelines. It describes how ESMO guidelines are created through an editorial board and author/reviewer process, or through consensus conferences involving multidisciplinary experts. The consensus conference process involves a pre-conference working group reviewing evidence, a 2-day conference to discuss recommendations, and post-conference finalization. ESMO guidelines are published annually in Annals of Oncology and translated into multiple languages to disseminate best practices for cancer treatment.
This document provides guidance on writing effective abstracts. It discusses what abstracts are, why they are important, and different types of abstracts such as unstructured and structured. Key elements that should be included in abstracts are background, objectives, methods, results, and conclusions. Tips are provided such as explaining abbreviations, using synonyms, and refraining from citations. The importance of keywords for searchability is covered, including reviewing similar articles and MeSH terms. Overall, the document aims to help authors write abstracts that accurately summarize their work and allow other researchers to easily find the information.
Enhancing the quality and transparency of health research: Introducing the PR...Thomas Bandholm
This lecture was held September 14 in Aalborg, Denmark at a PhD Forum (symposium). I hope you find it useful. Kind regards Thomas Bandholm (Twitter@TBandholm).
Dr. Paul Schumacker PhD provides an overview of the Red Journal's status, including a summary of its scientific scope, the editorial process, current Journal statistics, and future initiatives designed to attract submissions from junior investigators, and to promote the career development of new investigators who publish in the Journal.
The document summarizes the outcomes of a pilot project managed by Jisc Collections to extend journal subscriptions licensed for the UK academic sector to also provide access for NHS organizations in England. The pilot provided access to over 2,500 journal titles from 9 publishers and saw over 1 million article downloads in its first year. Acceptable pricing offers were negotiated with several major publishers but no funding was secured. Some temporary access was later funded. The document also discusses efforts to sustain national access in England to the Cochrane Database of Systematic Reviews as its publisher Wiley moves to an open access model and NICE funding is reduced.
This document provides guidelines for evaluating patients with pulmonary nodules from the American College of Chest Physicians. It summarizes the guideline objectives, target population, diagnostic and management interventions considered, major outcomes, methodology, recommendations, and validation process. The guideline was developed through a systematic review of literature and expert consensus to provide evidence-based recommendations. It defines solitary pulmonary nodules and provides 12 major recommendations on pre-test probability assessment, imaging tests, PET scanning, discussion of risks/benefits with patients, and tissue diagnosis.
This document provides guidance on publishing research in the journal AJP-Lung. It discusses the importance of publication for career advancement and continued funding. It outlines best practices for authorship, including determining author order and meeting authorship criteria. The submission and review process is described, including timelines, criteria for acceptance/rejection, and responding to reviewer feedback. Ethical issues in publishing like plagiarism, data fabrication, and authorship disputes are also covered. The document aims to help researchers successfully publish their work in AJP-Lung.
Ajp lung accomplishments 2015-updated by sm 3_31_2016amcever
The American Journal of Physiology-Lung Cellular and Molecular Physiology annual report summarizes accomplishments and challenges in 2015-2016. Key accomplishments include a 20% increase in research manuscript submissions, an increased impact factor of 4.08 making it the highest ranked basic lung research journal, and a 60% acceptance rate for research manuscripts. The journal also published three of the most highly cited articles among all APS journals and selected thirteen manuscripts for the APSselect program which highlights innovative, high impact research.
Can Cardiovascular Disease be PreventedParticipantsA.docxhumphrieskalyn
Can Cardiovascular Disease be Prevented?
Participants
:
Alfred A. Bove, MD, PhD, F
Robert S. Schwartz, MD, FACC
COPYRIGHT 2012 Healthology Inc.
Cardiovascular disease affects all aspects of heart function, from the arteries that supply it with blood, to the valves to the heart muscle itself.
RICHARD P. LEWIS, MD: Cardiovascular disease is the commonest chronic illness in our society, and I think in the world now. It causes about half of the deaths in our country today in one form or another, either as a heart attack or sudden death or dying of congestive heart failure.
Strokes are also a manifestation of cardiovascular disease, and a final one is called intermittent claudication, which is disease to the leg blood vessels that may lead to an amputation of the legs if it's severe.
ANNOUNCER: There are factors that can add to a patient's risk for the disease.
SUZANNE HUGHES, MSN, RN: There are only three risk factors for heart disease that we can't change. We haven't found the Fountain of Youth, so we can't turn back the clock: Age is a huge risk factor for cardiovascular disease. Being a man early in life is a risk factor for heart disease, which certainly is not changeable. And then the third thing is that we can't choose our parents. Family history is a risk factor for cardiovascular disease.
ANNOUNCER: Different medications can be prescribed to help prevent or control cardiovascular disease
ADOLPH M. HUTTER, Jr., MD: There are a number of medications that are actually very effective in preventing heart attacks and other forms of atherosclerosis. One is the simple drug aspirin. Aspirin has been shown to reduce strokes in women and heart attacks in men.
Another very important class of drugs are the drugs called statins. The statins are drugs that lower the bad cholesterol, the LDL. They lower it very effectively, and many studies have shown that these drugs can prevent the onset of heart disease and the progression of heart disease if you already have it.
A class of drugs called beta blockers can be very effective in protecting people who have already had a heart attack. They're also helpful in controlling blood pressure and controlling angina, which is a symptom of chest discomfort due to a blockage in the artery.
ANNOUNCER: It is also crucial that a patient makes lifestyle modifications.
ADOLPH M. HUTTER, Jr., MD: Heart disease is very preventable. You must absolutely stop smoking. You must have a low cholesterol, particularly the low bad cholesterol, the LDL. You must have your blood pressure controlled. You should exercise regularly and keep a lean weight.
RICHARD P. LEWIS, MD: We have made enormous strides in treating cardiovascular disease in all types. We can prevent the progression of this disease or the occurrence of clinically significant disease with our modern treatments if people will but do them. And it's not a disaster, even if you have the disease
Source Citation :
Can Cardiovascular Disease be Prevented? Alfre ...
The meeting agenda provided an update on research activities and future plans for the REG Interstitial Lung Disease Working Group. David Price discussed ongoing and upcoming research studies, publications, and events. Future plans included a revised staffing structure, working group and council structure, and upcoming events in 2015 and 2016. The meeting also discussed driving quality standards, perspectives from industry supporters, and new funding opportunities like PCORI. An open discussion period concluded the meeting to gather feedback and ideas.
How to Read a Research Article? By Dr. Nizar Saleh Abdelfattah, 2017Kareem Alnakeeb
This presentation is created by Dr. Nizar Saleh Abdelfattah in 2017. He used it in his episodes of "Research Fundamentals For Dummies" on YouTube.
https://www.youtube.com/playlist?list=PLuDFktFSWZ_XVufo7h9bDIerKoo7s3ouA
* The original presentation on Mediafire:
http://www.mediafire.com/file/mu5dml695g5r8qf/How-to-Research-by-Nizar-Abdelfattah.pptx/file
This document lists the collaborations and conflicts of interest for speakers Thomas F. Lüscher and Marco Metra. It notes that they have received research grants, educational grants, and honoraria from numerous pharmaceutical companies. The rest of the document discusses the European Heart Journal, including new associate editors, submission rates and acceptance rates, impact factors, and plans to launch new open access and supplement journals.
Getting the Measure of Analytics: Using bibliometrics and usage statistics to...Fintan Bracken
Presentation by Fintan Bracken and Arlene Healy entitled 'Getting the Measure of Analytics: Using bibliometrics and usage statistics to evaluate e-journals' delivered at the Academic & Special Libraries Section Annual Conference 2015 'The inside out library: collaboration, inspiration, transformation' in The Gibson Hotel, Dublin on 26th February 2015
Fintan Bracken & Arlene Healy presentation 'Getting the measure of analytics' delivered at #asl2015 'The inside out library: collaboration, inspiration, transformation' Feb 27th 2015
This document discusses electronic publishing (e-publishing) and impact factors (IF). It explains that e-publishing includes open access, and that impact factors are a measure of the frequency with which articles in a journal are cited. The document also lists several references on topics like how to write papers, guidelines for scientific publication, plagiarism, and publication ethics.
- Patrick W. Serruys is the editor-in-chief of EuroIntervention, which has reached its 10th anniversary as the official journal of the European Association of Percutaneous Cardiovascular Interventions.
- Over the past 10 years, the journal has grown tremendously due to the need to publish impactful presentations from EuroPCR and innovations from young cardiologists, as well as its inclusion in PubMed and increasing impact factor.
- The editorial board has played a key role in the journal's success through their expertise, enthusiasm, and awareness of current developments in the field.
Primer in quality improvement in radiology departmentAhmed Bahnassy
This document provides guidance on developing and implementing a quality improvement plan for a radiology department. It discusses identifying areas for improvement, collecting relevant data, setting targets, developing a work plan, implementing changes, monitoring results, and continually refining the process. Key aspects of quality improvement covered include using tools like fishbone diagrams and SWOT analyses to identify root causes of issues, applying the PDSA (Plan-Do-Study-Act) cycle of testing changes, and developing standardized reporting templates to improve consistency and communication. Examples of specific quality improvement projects focused on areas like lumbar spine MRI reporting and management of indeterminate pulmonary nodules are also provided.
The document discusses the first five years of publication of the Annals of Pakistan Institute of Medical Sciences (Annals of PIMS) journal from 2005 to 2009. Over these five years, the journal published 335 papers across various categories and specialties. The journal has provided a platform for disseminating medical research and works to improve through developing clear editorial policies and increasing its indexing in databases. Going forward, the journal aims to further improve quality, increase citations, and pursue indexing in international databases.
This document summarizes the structure and process for developing ESMO (European Society for Medical Oncology) clinical practice guidelines. It describes how ESMO guidelines are created through an editorial board and author/reviewer process, or through consensus conferences involving multidisciplinary experts. The consensus conference process involves a pre-conference working group reviewing evidence, a 2-day conference to discuss recommendations, and post-conference finalization. ESMO guidelines are published annually in Annals of Oncology and translated into multiple languages to disseminate best practices for cancer treatment.
This document provides guidance on writing effective abstracts. It discusses what abstracts are, why they are important, and different types of abstracts such as unstructured and structured. Key elements that should be included in abstracts are background, objectives, methods, results, and conclusions. Tips are provided such as explaining abbreviations, using synonyms, and refraining from citations. The importance of keywords for searchability is covered, including reviewing similar articles and MeSH terms. Overall, the document aims to help authors write abstracts that accurately summarize their work and allow other researchers to easily find the information.
Enhancing the quality and transparency of health research: Introducing the PR...Thomas Bandholm
This lecture was held September 14 in Aalborg, Denmark at a PhD Forum (symposium). I hope you find it useful. Kind regards Thomas Bandholm (Twitter@TBandholm).
Dr. Paul Schumacker PhD provides an overview of the Red Journal's status, including a summary of its scientific scope, the editorial process, current Journal statistics, and future initiatives designed to attract submissions from junior investigators, and to promote the career development of new investigators who publish in the Journal.
The document summarizes the outcomes of a pilot project managed by Jisc Collections to extend journal subscriptions licensed for the UK academic sector to also provide access for NHS organizations in England. The pilot provided access to over 2,500 journal titles from 9 publishers and saw over 1 million article downloads in its first year. Acceptable pricing offers were negotiated with several major publishers but no funding was secured. Some temporary access was later funded. The document also discusses efforts to sustain national access in England to the Cochrane Database of Systematic Reviews as its publisher Wiley moves to an open access model and NICE funding is reduced.
This document provides guidelines for evaluating patients with pulmonary nodules from the American College of Chest Physicians. It summarizes the guideline objectives, target population, diagnostic and management interventions considered, major outcomes, methodology, recommendations, and validation process. The guideline was developed through a systematic review of literature and expert consensus to provide evidence-based recommendations. It defines solitary pulmonary nodules and provides 12 major recommendations on pre-test probability assessment, imaging tests, PET scanning, discussion of risks/benefits with patients, and tissue diagnosis.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxEduSkills OECD
Iván Bornacelly, Policy Analyst at the OECD Centre for Skills, OECD, presents at the webinar 'Tackling job market gaps with a skills-first approach' on 12 June 2024
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Gender and Mental Health - Counselling and Family Therapy Applications and In...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
2. • AJP Lung is dedicated to publishing high-quality original and review articles
on all aspects of lung physiology, biochemistry and cell biology, as well as,
results of hypothesis driven clinical trials.
• We believe that all manuscripts are worthy of review.
We strive to provide timely and in depth reviews that will be helpful to
the authors
The Associate Editors synthesize the major comments of all reviewers
and tell the authors know what needs to be done for a paper to move
forward.
• We aim to increase the visibility of AJP-Lung in the lung community by:
Issuing calls for papers in timely areas of research
Sponsoring and organizing symposia in national meetings
Highlighting the best papers in our electronic media
Urging our colleagues and students to publish their papers in AJP-Lung
My Philosophy and Plans for AJP-Lung
The American Journal of Physiology Lung Cellular and Molecular Physiology:
“The best place to publish basic, translational, and hypothesis-driven clinical
lung research” January 1, 2012: L1-L3.
3. Deputy Editor
Y. S. Prakash, M.D., Ph.D.
Associate Editors
James F. Collawn, Ph.D.
Lester Kobzik, M.D.
Wolfgang M. Kuebler, M.D.
Dolly Mehta, Ph.D.
Rory E. Morty, Ph.D.
Rakesh P. Patel, M.D. (till 7/1/2015)
Irina Petrache, M.D. (new as of 1/1/2015)
Larissa Akimi Shimoda, Ph.D. (new as of 1/1/2015)
Kurt R. Stenmark, Ph.D. (till 7/1/2015)
The Associate Editors: We added two
Associate Editors as of 1/2015.
We are interested in recruiting two more associate editors
as of July 2015. We welcome nominations and self-
nominations in under-represented areas of lung research
4. Major Challenges for AJP-Lung on 1/1/2012
1. The impact factor was lower that of other
lung journals publishing basic science articles
2. A continuous decline in the number of
submitted research manuscripts since 2010
3. It took too long to reach the first decision on
research manuscripts
4. The visibility of AJP-Lung among junior
members of the pulmonary community
lagged behind other journal
5. Impact Factor
2010 2011 2012 2013
ARRCCM* 9.09 11.08 11.04 11.986
THORAX* 6.525 6.84 8.376 8.562
ERJ* 5.922 5.895 6.355 7.125
AJRCMB 4.426 5.125 4.148 4.109
AJP-Lung 4.137 3.662 3.523 4.041
Resp. Res 3.127 3.336 3.642 3.38
* Publish mainly clinical articles (basic science article should contain
data on human subjects)
Major Accomplishment:We have closed
the IF gap and moved ahead of competitors
6. Very good news!!
According to the H-index (“an index that attempts
to measure both the productivity and impact of
the published work of a scientist or scholar or
journal”), we are currently the top ranked journal,
publishing non-clinical pulmonary research
articles.
http://www.scimagojr.com/ journalrank. php?
category=2740)
7. Very good news!!
• There was an 8% increase in research
manuscripts submitted in 2014 as compared
to 2013. This is the first time in four years that
there was an increase in submitted
manuscript (see next slide).
• As of the end of February 2015, there is a 38%
increase of research manuscripts compared to
2014. Please keep them coming!!!
9. Major Accomplishment
We decreased the time to first decision
(Thank you Amy McEver)
# days to first decision
2010 2011 2012 2013 2014
31.6 29.45 23.14 22.61 22.32
Acceptance rates for research man.
45% 51% 51% 61% 51%
Range among AEs in 2014: 16-26 days
10. • Our editorial assistant, Ms. Amy McEver, contacts
reviewers after 14 days from the original assignment,
reminding them that their review is due.
• If the review has not been received by 16-18 days, we
contact the AE and ask her (him) whether they prefer to
contact the reviewer or whether the Editor should.
• Consistently, the reviews are received within a day or so
after a personal email from the editor.
• Most important: it takes less than ten days (on average)
to reach a decision on a revised manuscript.
Our Editorial Policy: Chasing Reviewers
11. # of Citations of AJP-Lung Articles
(as of 2/1/2015; Google Scholar)
Edit. Persp. Res. Res. Reviews
CFP
2012 5 23 12 10 27
(1-24 ) (1-72) (68-2) (32-3) (47-12)
2013 2 11 6 5 13
(5-0) (29-4) (29-0) (14-1) (24-7)
CFP: Calls for Papers
Means (Max-Min)
12. 2012-2013 2012-2013 2013 2013
ASSOCIATE EDITORS
# of man.
Published
# of man.
Published in
AJP-Lung
#Total Manuscripts
Published
# Total Manuscripts
Published in AJP-
Lung
9 0 4 0
8 4 5 2
13 1 9 1
18 2 7 1
9 1 2 1
12 3 7 3
22 0 10 0
23 5 10 1
30 4 12 1
23 10 11 5
Total 167.00 30.00 77.00 15.00
% 17.96 19.48
Publications by AE/Editor:
Total vs. published in AJP-Lung
13. Am J Physiol Lung Cell Mol Physiol. 2014 Dec
15;307(12):L911-6. doi: 10.1152/ajplung.00330.2014.
Epub 2014 Nov 7
.
A critical review of the American Journal of
Physiology-Lung Cellular and Molecular Physiology:
2012-2015. Matalon S PMID: 25381028
Major Accomplishments
A list of major accomplishments and challenges
are listed in a recent publication by the editor
14. Major Accomplishments
(PMID: 25381028)
• Published nine articles on the history of pulmonary
medicine (eight of them by Dr. John West).
• Established two new features with the consent of the
APS Publications Committee:
Rapid Reports, to allow the rapid dissemination of new
and important findings in the absence of a complete
story); and
Innovative Methodology articles, which describe novel
methods and techniques.
15. • Established a Facebook Page (http://ajplung.physiology.org/) and
a Blog (http://bit.ly/1gnt61m) dedicated to the promotion of AJP-
Lung. We highlight papers and post items of interest to the
pulmonary community
• Recognized the outstanding contributions of “junior” authors by
establishing “The most Outstanding Paper by a Junior
Investigator” awards; there were three awards in 2012 and five in
2013. Each award carried a $500 price funded by the Editor’s
fungible budget. Awardees were expected to contribute an
original article or review to AJP-Lung within a year from
receiving their award.
• Established the Hermann Rahn (2014) and Usha Prakash (2015)
awards for outstanding papers published in AJP-Lung using
private funds.
Winners of these awards for 2014 and 2015 are listed in our
Facebook page.
Major Accomplishments (PMID: 25381028)
16. • Assembled and posted a list of the most highly cited
papers published in AJP-Lung during the last 20 years
(http://ajplung.physiology.org/front.most-cited)
• Published two retrospective reviews (edited by Dr. Lester
Kobzik) by the senior authors of two of the most highly
cited papers.
• Published four Physiology in Medicine reviews
• Published six state-of-the-art reviews from Associate
Editors highlighting and integrating findings in research
manuscripts in AJP-Lung, with what was published
elsewhere
• Published two “position” papers, along with a commentary
from Dr. Weibel, intended as primers on quantitative lung
morphology (edited by Dr. Morty).
Major Accomplishments (PMID: 25381028)
17. • In an effort to increase the visibility of AJP-Lung and attract more papers,
we sponsored three symposia in international societal meetings.
• Funds from these symposia were provided by the fungible accounts of the
Editor and Associate Editors. Invited speakers were encouraged (but not
required) to submit manuscripts on the topic of their talk to AJP-Lung. (see
https://www. Facebook. com/AJPLung for more details)
EB 2014
1. The Enigma Variations: The Many Faces of the Myofibroblast in Fibrotic
Disease. Rachel C. Chambers (Assoc. Ed.), Paul F. Mercer (Editorial Board
Member)
2. Bioengineering the Cardiopulmonary System: From Molecules to
Mechanics. YS Prakash, Kurt R. Stenmark. (A perspective with contributions
from the invited speakers as well as summarizing the impact of papers
published in AJP-Lung in response to the calls for papers is currently in
preparation by Drs. Prakash and Stenmark).
Association of University Anesthesiologists, 61st Annual Meeting
http://auahq.org/aua-brochure-final-3-25-14.pdf
3. Plenary Session, “Lung Injury Remodeling and Repair.” Research
Symposium by Sadis Matalon, Prakash YS (Deputy Editor, and Charles W.
Emala, Editorial Board Member)
Major Accomplishments (PMID: 25381028)
18. • I send detailed reports on the state-of-AJP-Lung to AEs every
two months and to members of the Editorial Board twice a year
and solicited input on several issues. Dr. Hershel Raff was
copied on these emails. The AEs and I meet every year at EB
and hold web-conferences quarterly. I always seek advice from
the AEs on all new initiatives.
• Thirty five senior members (who did not have time to review
manuscripts) with ten mid-career scientists
• Ten phenomenal mid-career scientists joined our editorial
board. All members of the editorial board are expected to
accepte at least 50% of invitations to review manuscripts and
publish one article per year in AJP-Lung.
• I appointed five senior members of the pulmonary community
as Consulting Editors to provide sage advice on all issues
(see http://www.the-aps.org/mm /Publications /Journals/AJP-
Lung/Ed-Board for a complete list of AEs, CEs and EB members)
Major Accomplishments
19. Looking forward: Increasing the upward momentum
Increase the number of submitted manuscripts
New Calls for Papers on timely, clinically relevant, and
controversial topics (please see
http://ajplung.physiology.org/ for existing calls for
papers. New ideas are always welcome.
We have invited a number of outstanding scientists to
contribute reviews, perspectives and Physiology in
Medicine articles to be published in 2015. Please
remember that we welcome ideas for reviews.
Each Editorial Board Member must submit at least
one paper per year.
20. • Institute a new feature (“Paper of the Month”) to better
recognize outstanding papers. This paper will be
highlighted on our Facebook and blog pages with a brief
commentary.
• Seek input from the Consulting Editors on perceived
areas of weaknesses and recruit a new AEs to fill the
gap
• Continue the tradition of providing fair, thorough, helpful,
and timely reviews of all articles submitted to AJP-Lung.
Decrease the time to first submission under 20 d.
• Continue to promote AJP-Lung as the best place to
publish articles on all aspects of lung research.
Looking forward: Increasing the upward momentum
21. Thank you to:
• The Associate Editors
• The Consulting Editors
• The Editorial Board members
• Amy McEver, Editorial Assistant
• Drs. Hershel Raff and Curt D, Sigmund, Chairs of the APS
Publication Com.
• Ms. Rita Scheman, Head of Publications
• Christina Bennett, Ethics
• Michael Gentry, Online Production Editor
• Ellyn Kestnbaum, Journal Supervisor
• Eric Pesanelli, Editorial Art Manager
• Gil Ebner, Peer Review Manager
• Mona Trang, Peer Review Coordinator